A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation

Iris Lavon; Tatiana Sheinin; Sigal Meilin; Efrat Biton; Ayelet Weksler; Gilat Efroni; Avi Bar-Joseph; George Fink; Ayelet Avraham

doi:10.1124/mol.64.6.1334

Research ArticleArticle

A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation

Iris Lavon, Tatiana Sheinin, Sigal Meilin, Efrat Biton, Ayelet Weksler, Gilat Efroni, Avi Bar-Joseph, George Fink and Ayelet Avraham

Molecular Pharmacology December 2003, 64 (6) 1334-1341; DOI: https://doi.org/10.1124/mol.64.6.1334

Iris Lavon

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tatiana Sheinin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sigal Meilin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Efrat Biton

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ayelet Weksler

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gilat Efroni

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Avi Bar-Joseph

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

George Fink

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ayelet Avraham

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

Molecular Pharmacology

Vol. 64, Issue 6

1 Dec 2003

Table of Contents
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation

Message Subject (Your Name) has forwarded a page to you from Molecular Pharmacology

Message Body (Your Name) thought you would be interested in this article in Molecular Pharmacology.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Research ArticleArticle

A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation

Iris Lavon, Tatiana Sheinin, Sigal Meilin, Efrat Biton, Ayelet Weksler, Gilat Efroni, Avi Bar-Joseph, George Fink and Ayelet Avraham

Molecular Pharmacology December 1, 2003, 64 (6) 1334-1341; DOI: https://doi.org/10.1124/mol.64.6.1334

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Research ArticleArticle

A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation

Iris Lavon, Tatiana Sheinin, Sigal Meilin, Efrat Biton, Ayelet Weksler, Gilat Efroni, Avi Bar-Joseph, George Fink and Ayelet Avraham

Molecular Pharmacology December 1, 2003, 64 (6) 1334-1341; DOI: https://doi.org/10.1124/mol.64.6.1334

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation

Plain text

Vertical Tabs

Jump to comment:

In this issue

A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals